Effects of testosterone on norepinephrine release in isolated rat heart

被引:0
作者
Xiaofei Wang
Yanzhou Zhang
Jun Bu
Linghong Shen
Ben He
机构
[1] Shanghai Jiao Tong University School of Medicine,Department of Cardiology, Ren Ji Hospital
[2] the First Affiliated Hospital of Zhengzhou University,Department of Cardiology
来源
Journal of Huazhong University of Science and Technology [Medical Sciences] | 2012年 / 32卷
关键词
testosterone; ischemia-reperfusion; norepinephrine; ventricular fibrillation;
D O I
暂无
中图分类号
学科分类号
摘要
The effects of testosterone on norepinephrine release were investigated in the isolated rat hearts. Sprague-Dawley male rats (n=120) were randomized to testosterone and control groups. The rats in testosterone group were perfused with modified Krebs-Henseleit buffer containing different concentrations of testosterone (0.1, 1.0, 10.0, and 100.0 nmol/L, respectively). Myocardial ischemia was induced by globally stopping the perfusion flow. Exocytotic norepinephrine release was induced by electrical field stimulation at 5 V (effective voltage) and 6 Hz (pulse width of 2 ms) for 1 min. The overflow of norepinephrine was determined by high pressure liquid chromatography and electrochemical detection (HPLC-EC). Following acute ischemia, testosterone (1.0, 10.0 and 100.0 nmol/L) significantly reduced norepinephrine release (P<0.01), and the norepinepherine overflow was similar between the control and 0.1 nmol/L testosterone group (P>0.05). Electrical stimulation of the ventricle evoked norepinepherine release, and this was diminished by the perfusion with testosterone at the concentrations of 1.0, 10.0 and 100.0 nmol/L (P<0.01). It is suggested that testosterone suppresses ischemia- and electrical stimulation-induced norepinepherine release in the isolated rat hearts.
引用
收藏
页码:42 / 46
页数:4
相关论文
共 55 条
  • [1] Kurz T.(1995)Nonexocytotic noradrenaline release and ventricular fibrillation in ischemic rat hearts Naunyn Schmiedebergs Arch Pharmacol 352 491-496
  • [2] Offner B.(2003)Hormonal profile in patients with congestive heart failure Int J Cardiol 287 179-183
  • [3] Schreieck J.(2004)The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men J Clin Endocrinol Metab 89 3313-3318
  • [4] Kontoleon P.E.(2004)Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life Heart 90 871-876
  • [5] Anastasiou-Nana M.I.(2002)Effect of oral administration of testosterone on brachial arterial vasoreactivity in men with coronary artery disease Am J Cardiol 89 862-864
  • [6] Papapetrou P.D.(1999)Testosterone and other anabolic steroids as cardiovascular drugs Am J Ther 6 167-174
  • [7] Malkin C.J.(2006)Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial Eur Heart J 27 57-64
  • [8] Pugh P.J.(2003)Acute haemodynamic effects of testosterone in men with chronic heart failure Eur Heart J 24 909-915
  • [9] Jones R.D.(2007)Effects of testosterone on cytokines and left ventricular remodeling following heart failure Cell Physiol Biochem 20 847-852
  • [10] Malkin C.J.(1988)The Lambeth conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion Cardiovasc Res 22 447-455